World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
70
Citations
19043
World Ranking
6954
National Ranking
531

J. Michael Conlon publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where J. Michael Conlon sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 491 publications — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

J. Michael Conlon D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where J. Michael Conlon sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 70 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

J. Michael Conlon is affiliated with the University of Ulster in the United Kingdom and has contributed extensively to the field of medicine, with a focus on molecular biology, endocrinology, diabetes and metabolism, microbiology, surgery, and pulmonary and respiratory medicine. Their research spans 54 publications in medicine, including 18 specifically related to molecular biology and 15 on endocrinology, diabetes, and metabolism.

The primary topics of J. Michael Conlon's work include antimicrobial peptides and activities, diabetes treatment and management, pancreatic function and diabetes, biochemical and structural characterization, respiratory support and mechanisms, venomous animal envenomation and studies, and sepsis diagnosis and treatment. These topics reflect diverse interests, bridging biochemical mechanisms and clinical applications.

Among their recent publications are the following works:

  • Isolation and characterization of cytotoxic and insulin-releasing components from the venom of the black-necked spitting cobra Naja nigricollis (Elapidae), 2020, Toxicon X
  • An update on peptide-based therapies for type 2 diabetes and obesity, 2023, Peptides
  • Strategies for improving stability and pharmacokinetic characteristics of radiolabeled peptides for imaging and therapy, 2020, Peptides
  • Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial, 2022, Critical Care
  • Effect of total cholesterol and statin therapy on mortality in ARDS patients: a secondary analysis of the SAILS and HARP-2 trials, 2023, Critical Care

The scientist frequently publishes in journals such as AEA Randomized Controlled Trials (17 publications), Peptides (16 publications), Antibiotics (3 publications), Critical Care (2 publications), and Thorax (2 publications). This indicates a sustained engagement with peer-reviewed platforms that cover clinical trials, peptide research, antimicrobial studies, respiratory medicine, and critical care topics.

J. Michael Conlon collaborates regularly with several researchers, including:

  • Peter R. Flatt (15 coauthored works)
  • Jérôme Leprince (8 coauthored works)
  • Milena Mechkarska (8 coauthored works)
  • Daniel F. McAuley (7 coauthored works)
  • Cecilia O'Kane (6 coauthored works)

Best Publications

  • Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord

    Yolaine Coulouarn;Isabelle Lihrmann;Sylvie Jegou;Youssef Anouar

  • Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents.

    J.Michael Conlon;Jolanta Kolodziejek;Norbert Nowotny;Norbert Nowotny

  • Primary structure and biological activity of a third gonadotropin-releasing hormone from lamprey brain.

    S. A. Sower;Yueh-Chin Chiang;S. Lovas;J. M. Conlon

  • Antimicrobial peptide defenses against chytridiomycosis, an emerging infectious disease of amphibian populations

    Louise A. Rollins-Smith;J. Michael Conlon

  • Activity of antimicrobial skin peptides from ranid frogs against Batrachochytrium dendrobatidis, the chytrid fungus associated with global amphibian declines

    Louise A Rollins-Smith;Cynthia Carey;Joyce Longcore;Jennifer K Doersam

  • Effects of chytrid and carbaryl exposure on survival, growth and skin peptide defenses in foothill yellow-legged frogs.

    Carlos Davidson;Michael F. Benard;H. Bradley Shaffer;John M. Parker

  • Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents

    J. Michael Conlon;J. Michael Conlon;Milena Mechkarska;Miodrag L. Lukic;Peter R. Flatt

  • Structural diversity and species distribution of host-defense peptides in frog skin secretions

    J. Michael Conlon

  • Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens.

    Jadvinder Goraya;Yuqi Wang;Zhihong Li;Martina O'Flaherty

  • Antimicrobial Peptides from Amphibian Skin Potently Inhibit Human Immunodeficiency Virus Infection and Transfer of Virus from Dendritic Cells to T Cells

    Scott E. VanCompernolle;R. Jeffery Taylor;Kyra Oswald-Richter;Jiyang Jiang

  • The contribution of skin antimicrobial peptides to the system of innate immunity in anurans

    J. Michael Conlon

  • Measurements of somatostatin-like immunoreactivity in plasma

    Virginia Harris;J.Michael Conlon;Coimbatore B. Srikant;Kay McCorkle

  • Multiple antimicrobial peptides and peptides related to bradykinin and neuromedin N isolated from skin secretions of the pickerel frog, Rana palustris.

    Yousef J. Basir;Floyd C. Knoop;Joseph Dulka;J.Michael Conlon

  • Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae.

    J. Michael Conlon

  • Scyliorhinin I and II: two novel tachykinins from dogfish gut

    J.Michael Conlon;Carolyn F. Deacon;Liam O'Toole;Lars Thim

  • Antimicrobial peptides from the skins of North American frogs

    J. Michael Conlon;Jolanta Kolodziejek;Jolanta Kolodziejek;Norbert Nowotny

  • Primary structure of frog pituitary adenylate cyclase-activating polypeptide (PACAP) and effects of ovine PACAP on frog pituitary

    Nicolas Chartrel;Marie-Christine Tonon;Hubert Vaudry;J. Michael Conlon

  • Somatostatin- and urotensin II-related peptides: molecular diversity and evolutionary perspectives

    J.Michael Conlon;Herve Tostivint;Hubert Vaudry

  • Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents.

    J. Michael Conlon;Nadia Al-Ghaferi;Bency Abraham;Jérôme Leprince

  • Ranatuerins: Antimicrobial Peptides Isolated from the Skin of the American Bullfrog, Rana catesbeiana

    Jadvinder Goraya;Floyd C. Knoop;J.Michael Conlon

Frequent Co-Authors

Hubert Vaudry
Hubert Vaudry University of Rouen
Jérôme Leprince
Jérôme Leprince University of Rouen
Thierry Jouenne
Thierry Jouenne University of Rouen
Peter R. Flatt
Peter R. Flatt University of Ulster
Norbert Nowotny
Norbert Nowotny University of Veterinary Medicine Vienna
Lars Thim
Lars Thim Novo Nordisk (Denmark)
Louise A. Rollins-Smith
Louise A. Rollins-Smith Vanderbilt University
Marie-Christine Tonon
Marie-Christine Tonon University of Rouen
Maria Luisa Mangoni
Maria Luisa Mangoni Sapienza University of Rome
Dan Larhammar
Dan Larhammar Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing J. Michael Conlon

Trending Scientists

Recently Published Articles